Clinical Trial Update: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating sirolimus with hydroxychloroquine in women with lymphangioleiomyomatosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Lymphangioleiomyomatosis | Phase 1 | Status: COMPLETED | Results posted: 2018-10-11